April 14, 2019
Vital Therapies, Precipio, Chimerix, ContraFect and PhaseBio Pharmaceuticals were last week's top gainers.
April 9, 2019
PhaseBio Pharmaceuticals (NASDAQ:PHAS) has announced it has licensed the global rights of PB1023 to ImmunoForge. PB1023 is a recombinant GLP-1...
March 31, 2019
Aveo Pharmaceuticals, Curis, Phasebio Pharmaceuticals, Arcturus Therapeutics and Krystal Biotech were last week's top gainers.
December 16, 2018
Innovate Biopharmaceuticals, Aridis Pharmaceuticals, Imprimis Pharmaceuticals, Achaogen and SynthoRx were last week's top gainers.